Pregnancy & Breastfeeding Psychopharmacology: Rapid Decision Guide

2026 CLINICAL update SERIES:

[FROM APRIL 18 ONWARDS]

(1) Antidepressant Use in Pregnancy & Breastfeeding

Quick Clinical Reference for Busy Clinicians 

— Individual Antidepressants Available for Rapid Review

ANTIDEPRESSANTS IN PREGNANCY:

  1. Executive Summary
    Quick, high-yield overview for rapid clinical decision-making
  2. Pregnancy Safety & Risks
    Fetal exposure, malformation risks, trimester-specific considerations
  3. Maternal Safety & Risks
    Relapse risk, untreated illness impact, adverse effects
  4. Pharmacokinetics & Dosing Nuances
    Trimester-based metabolism changes, dose adjustments
  5. Comparative Evidence Table 
    Latest data across antidepressants for quick comparison
  6. Clinic-Ready Tools: Patient Script
    Structured shared decision-making language
  7. Clinic-Ready Tools: EMR Documentation
    Pre-built templates to save time
  8. Clinical Pearl
    One-line takeaway for practice
  9. Medication Selection Flowchart
    Step-by-step framework to guide antidepressant choice based on clinical scenario

ANTIDEPRESSANTS WITH BREASTFEEDING:

  1. Executive Summary
    Quick, high-yield overview of medication safety during lactation for rapid clinical decision-making
  2. Lactation Safety & Infant Risks
    Drug transfer into breast milk, relative infant dose (RID), and reported adverse effects in infants
  3. Comparative Lactation Table
    Side-by-side comparison of antidepressants based on milk transfer, infant exposure, and safety data
  4. Clinical Management & Monitoring
    Guidance on infant monitoring, timing of dosing relative to feeds, and when to avoid or switch medications
  5. Clinic-Ready Tools: Patient Script
    Clear, structured language to support shared decision-making with breastfeeding patients
  6. Clinic-Ready Tools: EMR Documentation
    Pre-built templates to efficiently document risk–benefit discussions and clinical rationale
  7. Medication Selection Flowchart
    Practical decision pathway for selecting antidepressants during lactation

(2) Antipsychotics Use in Pregnancy & Breastfeeding

Quick Clinical Reference for Busy Clinicians 

— Individual Antipsychotics Available for Rapid Review

ANTIPSYCHOTICS IN PREGNANCY:

  1. Executive Summary
    Rapid, point-of-care overview to guide antipsychotic use during pregnancy
  2. Reproductive Safety & Teratogenicity
    Evidence on congenital malformations, trimester-specific risks, and class differences
  3. Clinical Risks to the Fetus and Neonate
    Neonatal adaptation syndrome, EPS/withdrawal, metabolic and obstetric considerations
  4. Maternal Management
    Relapse prevention, dose adjustments, metabolic monitoring, and risk–benefit balancing
  5. Clinic-Ready Tools: Patient Script
    Structured language for high-stakes shared decision-making
  6. Clinic-Ready Tools: EMR Documentation
    Pre-built templates to document clinical rationale and discussions
  7. Clinical Pearl
    High-yield takeaway for real-world prescribing
  8. Master Clinical Decision Flowchart
    Comprehensive framework integrating maternal stability, fetal risk, and medication selection

ANTIPSYCHOTICS WITH BREASTFEEDING:

  1. Executive Summary
    Quick clinical overview to support medication decisions during lactation
  2. Lactational Pharmacology: Transfer Data
    Breast milk levels, relative infant dose (RID), and pharmacokinetic considerations
  3. Clinical Impact on the Infant
    Sedation, feeding issues, developmental concerns, and reported adverse effects
  4. Clinical Management & Monitoring
    Infant monitoring strategies and practical prescribing considerations
  5. Clinic-Ready Tools: Patient Script
    Clear, structured language for discussing medication safety while breastfeeding
  6. Clinic-Ready Tools: EMR Documentation
    Time-saving templates to document shared decision-making
  7. Clinical Pearl
    Key takeaway for quick clinical recall
  8. Master Clinical Decision Flowchart
    End-to-end decision pathway for antipsychotic use during lactation

(3) Mood Stabilizers in Pregnancy & Breastfeeding

Quick Clinical Reference for Busy Clinicians 

— Individual Mood Stabilizers Available for Rapid Review

MOOD STABILIZERS IN PREGNANCY:

  1. Executive Summary
    Rapid, point-of-care overview to guide mood stabilizer use during pregnancy
  2. Teratogenic Profile: Risks & Malformations
    Medication-specific risks, congenital malformations, and trimester-based vulnerability
  3. Guidelines for Clinical Management
    Evidence-based strategies for continuation, switching, and risk–benefit balancing
  4. Comparison of Mood Stabilizer Safety
    Side-by-side comparison to identify preferred vs higher-risk agents
  5. Clinic-Ready Tools: Patient Script
    Structured language for complex shared decision-making discussions
  6. Clinic-Ready Tools: EMR Documentation
    Pre-built templates to document clinical rationale and risk–benefit analysis
  7. Clinical Pearl
    High-yield takeaway for real-world prescribing
  8. Clinical Selection & Decision Flowchart
    Structured approach for selecting and managing mood stabilizers in pregnancy

MOOD STABILIZERS WITH BREASTFEEDING:

  1. Executive Summary
    Quick clinical overview to support medication decisions during lactation
  2. The RID & Pharmacokinetic Profile
    Relative infant dose (RID), breast milk transfer, and drug-specific kinetics
  3. Clinical Risks to the Infant
    Sedation, toxicity risks, and medication-specific infant safety concerns
  4. Monitoring Protocol
    Infant monitoring strategies, lab considerations, and clinical follow-up
  5. Clinical Pearl: The “Postpartum Dose Reset”
    Key insight on dose adjustments after delivery and clinical implications
  6. Clinic-Ready Tools: Patient Script
    Clear, structured language for discussing medication use while breastfeeding
  7. Clinic-Ready Tools: EMR Documentation
    Time-saving templates to document shared decision-making
  8. Clinical Selection & Decision Flowchart
    Practical decision framework balancing maternal needs and infant safety

(4) ADHD Medications in Pregnancy & Breastfeeding

Quick Clinical Reference for Busy Clinicians 

— Individual ADHD Medications Available for Rapid Review

ADHD MEDICATIONS IN PREGNANCY:

  1. Executive Summary
    Rapid, point-of-care overview to guide ADHD medication use during pregnancy
  2. Class Comparison Table
    Side-by-side comparison of medications for quick clinical review
  3. Teratogenic Profile
    Medication-specific risks, congenital malformation data, and trimester-based considerations
  4. Management Strategy: The “Safe-Start” Protocol
    Practical framework for assessing severity, weighing risks and benefits, and guiding treatment decisions
  5. Clinic-Ready Tools: Patient Script
    Structured language for shared decision-making around ADHD treatment in pregnancy
  6. Clinic-Ready Tools: EMR Documentation
    Pre-built templates to document clinical rationale and counseling discussions
  7. Clinical Pearl
    High-yield takeaway for real-world prescribing
  8. Medication Selection Flowchart
    Structured approach to selecting ADHD medications options

ADHD MEDICATIONS WITH BREASTFEEDING:

  1. Executive Summary
    Quick clinical overview to support ADHD medication decisions during lactation
  2. The RID & Pharmacokinetic Profile
    Relative infant dose (RID), breast milk transfer, and medication-specific pharmacokinetic considerations
  3. Clinical Risks to the Infant
    Infant exposure concerns including irritability, sleep disruption, feeding issues, and growth monitoring
  4. Monitoring Protocol
    Practical guidance for infant monitoring, follow-up, and medication-specific precautions
  5. Clinical Pearl
    Key takeaway for rapid clinical recall
  6. Clinic-Ready Tools: Patient Script
    Clear, structured language for discussing ADHD medication use while breastfeeding
  7. Clinic-Ready Tools: EMR Documentation
    Time-saving templates to document shared decision-making and clinical justification
  8. Medication Selection Flowchart
    Decision pathway to balance maternal benefit and infant exposure

(5) Sleep Medicines in Pregnancy & Breastfeeding

Quick Clinical Reference for Busy Clinicians 

— Individual Sleep Medications Available for Rapid Review

SLEEP MEDICATIONS IN PREGNANCY:

  1. Executive Summary
    Rapid, point-of-care overview to guide sleep medication use during pregnancy
  2. Pregnancy Safety & Risks
    Fetal exposure risks, congenital malformation data, and trimester-specific considerations
  3. Comparative Study Table: Key Evidence
    Side-by-side comparison of commonly used sleep medications based on latest clinical data
  4. Maternal Safety & Risks
    Sedation, fall risk, dependency potential, and impact on maternal functioning
  5. Pharmacokinetics & Dosing Nuances
    Pregnancy-related metabolic changes and practical dosing considerations
  6. Clinic-Ready Tools: Patient Script
    Structured language for discussing risks, benefits, and alternatives with patients
  7. Clinic-Ready Tools: EMR Documentation
    Pre-built templates to document clinical decision-making and counseling
  8. Clinical Pearl
    High-yield takeaway for real-world prescribing
  9. Medication Selection Flowchart
    Stepwise framework for selecting safe and effective sleep medications

SLEEP MEDICATIONS WITH BREASTFEEDING:

  1. Executive Summary
    Quick clinical overview to support sleep medication decisions during lactation
  2. Lactation Safety & Infant Risks
    Breast milk transfer, sedation risk, and potential effects on infant feeding and alertness
  3. Comparative Lactation Table: Clinical Pharmacokinetics
    Comparison of medications based on milk transfer, half-life, and infant exposure
  4. Dosing Strategy
    Timing of doses relative to feeds, minimizing infant exposure, and selecting safer options
  5. Clinical Pearl
    Key takeaway for rapid clinical recall
  6. Clinic-Ready Tools: Patient Script
    Clear, structured language for shared decision-making
  7. Clinic-Ready Tools: EMR Documentation
    Time-saving templates to document risk–benefit discussions
  8. Medication Selection Flowchart
    Clinical pathway to minimize infant exposure while managing insomnia

Full Access Available to Academy Members

This clinical series is part of the Psychiatry Education Forum Academy and is available exclusively to enrolled members.

Designed for busy clinicians, the Academy provides structured, high-yield, point-of-care content across psychopharmacology—so you can make faster, more confident decisions in real-world practice.

If you’re looking for rapid medication-level guidance, standardized frameworks, and clinic-ready tools you can actually use during patient care, this is built for you.

Join the Academy to unlock full access to this and our 500+ clinically relevant chapters.

JOIN ACADEMY MEMBERSHIP

MONTHLY PLAN

$ 39 Per Month
  • Flexible Access
  • Monthly Billing
  • Cancel Anytime
  • Start Today

YEARLY PLAN

$ 150 Per Year
  • Best Value
  • Maximum Saving
  • Committed Learners
  • Most Popular
POPULAR

STUDENT PLAN

$ 99 Per Year
  • For Residents
  • For Students
  • Career Growth
  • Affordable Learning

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: [email protected]

© 2026 All Rights Reserved.